Medifast (MED) Finished Goods (2011 - 2021)

Medifast (MED) has 9 years of Finished Goods data on file, last reported at $100.7 million in Q3 2021.

• For the quarter ending Q3 2021, Finished Goods rose 387.59% year-over-year to $100.7 million; the trailing twelve-month figure through Sep 2021 stood at $100.7 million (up 387.59% YoY), and the FY2020 full-year result was $29.9 million, down 4.65% from the prior year.
• Finished Goods for Q3 2021 stood at $100.7 million, up from $73.1 million in the prior quarter.
• Across five years, Finished Goods topped out at $100.7 million in Q3 2021 and bottomed at $10.5 million in Q3 2017.
• The 5-year median for Finished Goods is $27.5 million (2018), against an average of $30.3 million.
• The widest annual swing landed in 2020, when Finished Goods plunged 38.84%; it then jumped 387.59% in 2021.
• A 5-year view of Finished Goods shows it stood at $13.4 million in 2017, then surged by 90.27% to $25.5 million in 2018, then rose by 22.76% to $31.3 million in 2019, then declined by 4.65% to $29.9 million in 2020, then surged by 237.22% to $100.7 million in 2021.
• The last three Finished Goods figures came in at $100.7 million (Q3 2021), $73.1 million (Q2 2021), and $40.5 million (Q1 2021), per Business Quant data.

Peer Comparison